

Recombinant Human IL-8 (CXCL8) (Carrier-free)
Cat No. | Size | Price | Quantity | |
---|---|---|---|---|
21-8089-U005 | 5 µg | $69.00 | ||
21-8089-U025 | 25 µg | $179.00 | ||
21-8089-U100 | 100 µg | $550.00 |
Description
Product Details
Name | Recombinant Human IL-8 (CXCL8) (Carrier-free) |
---|---|
Cat. No. | 21-8089 |
Alternative Names | monocyte-derived neutrophil chemotactic factor (MDNCF), neutrophil activating factor (NAF), NAP-1, NAP1 |
Amino Acid Sequence | SAKELRCQCI KTYSKPFHPK FIKELRVIES GPHCANTEII VKLSDGRELC LDPKENWVQR VVEKFLKRAE NS |
Authenticity | Verified by N-terminal and Mass Spectrometry analyses (when applicable). |
Bioactivity | Determined by its ability to chemoattract human peripheral blood neutrophils using a concentration range of 10.0-100.0 ng/ml. |
Endotoxin Level | Endotoxin level is <0.1 ng/μg of protein (<1 EU/μg). |
Molecular Mass | Recombinant human IL-8 (monocyte-derived) is an 8.4 kDa protein containing 72 amino acid residues. |
Protein Content | Content Verified by UV Spectroscopy and/or SDS-PAGE gel. |
Purity (%) | 98 |
Source | E. coli |
Reactivity | Human |
Research Areas | Angiogenesis/Cardiovascular; Apoptosis; Chemotaxis; Inflammation; Neurobiology; Wound Healing; Allergy; Transplantation |
Reconstitution | See Certificate of Analysis (COA) for lot specific reconstitution information. |
Application | Bioassay |
FC = Flow Cytometry; FA = Functional Assays; ELISA = Enzyme-Linked Immunosorbent Assay; ICC = Immunocytochemistry; IF = Immunofluorescence Microscopy; IHC = Immunohistochemistry; IHC-F = Immunohistochemistry, Frozen Tissue; IHC-P = Immunohistochemistry, Paraffin-Embedded Tissue; IP = Immunoprecipitation; WB = Western Blot; EM = Electron Microscopy
*Tonbo Biosciences tests all antibodies by flow cytometry. Citations are provided as a resource for additional applications that have not been validated by Tonbo Biosciences. Please choose the appropriate format for each application and consult the Materials and Methods section for additional details about the use of any product in these publications.